Good service means doing it right the first time, on time.
Bin Z., Bioanalytical Director
PBL senior managers are highly qualified, knowledgeable, experienced and focused.
Mike Y., Executive Vice President
The work can be challenging but I have learned so much and I know my efforts are appreciated.
Shaiela B., Client Account Manager
Outstanding regulatory compliance is the backbone of PBL.
Thomas C., Associate Vice President, Quality Assurance
Our facility is purpose built with cGMP and GLP compliance in mind.
Tom Spalding, President
Mart Spalding Sr. started PBL to provide an unmet need in the science community.
Tom Spalding, President
Small and Large Molecule Manufacturing Support.
Small and Large Molecule Development Support.
Immunogenicity and Bioanalysis for Clinical Trials.
Medical Device, Delivery Device, and Combination Product Services.
Access your reports, study and submission status, invoices, quotes and purchase order information all at one secure location on the web.
Pacific BioLabs is proud to announce successful accreditation for ISO 17025:2017, General Requirements for the Competence of Testing and Calibration Laboratories, through the ANSI-ASQ National Accreditation Board. PBL’s accreditation for ISO 17025:2017 replaces PBL’s past certifications for ISO 9001:2008 and ISO 13485:2003 and is considered more appropriate for a CRO. The scope for PBL’s 17025 […]
For their March issue, Medical Product Outsourcing Magazine interviewed Ryan Harper, PBL’s Business Development Director, regarding recent medical device testing changes and developments. The article discusses current industry trends, additions to ISO 10993, performing risk assessments as well as new technologies and approaches. The MPO article can be accessed here.
In 2018, Pacific BioLabs decided not to renew its ISO 9001 and ISO 13485 certificates, opting instead to become ISO 17025 certified. Being a testing lab and not a medical device manufacturer, ISO 17025 is more pertinent to PBL than 9001 and 13485. PBL understands that continuous improvement is crucial its success and we are […]
The BIO International Convention attracts over 16,000 biotech and pharmaceutical leaders from over 7,000 companies. Sessions span a wide spectrum including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy. The unique one-on-one partnering system provide a great way to meet new vendors, partners and investors.
